KAYLAN SCHEXNYDER: Open Payments
NPI 1669994794 · CARENCRO, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$982 in 36 payments from 11 companies in 2025. Trend: 2023 $156 · 2024 $299 · 2025 $982
Food & beverage: $884Education: $98
| Company | Payments | Amount |
|---|---|---|
| Optinose US, Inc. | 7 | $229 |
| Inspire Medical Systems, Inc. | 9 | $210 |
| Axsome Therapeutics, Inc. | 5 | $143 |
| Regeneron Healthcare Solutions, Inc. | 3 | $137 |
| GENZYME CORPORATION | 4 | $106 |
| Lilly USA, LLC | 3 | $46 |
| Paratek Pharmaceuticals, Inc. | 1 | $32 |
| Amgen Inc. | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Hikma Pharmaceuticals USA | 1 | $17 |
Products named: Xhance, DUPIXENT, INSPIRE, Sunosi, ZEPBOUND, TEZSPIRE, KEYTRUDA, Ryaltris.
Industry payments across LA — which companies pay providers there.
